Successful treatment of multicentric Castleman's disease with intracranial and retroperitoneal tumors.
Yoshida
K
K
The First Department of Internal Medicine, Saitama Medical School, Iruma-gun.
Suzuki
T
T
Sakata
T
T
Kawai
N
N
Matsuda
A
A
Kayano
H
H
Hirashima
K
K
Matsutani
M
M
Bessho
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D005871:Castleman Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D015850:Interleukin-6 / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D018714:Radiotherapy, Adjuvant; D012008:Recurrence; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D015850:Interleukin-6